1 Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis Journal of the National Cancer Institute, April 18, 2013 Evidence Based Medicine
2 The Prevalence and Prognostic Role of Vitamin D Deficiency in Patients with Acute Coronary Syndrome Heart, Lung, and Circulation, April 30, 2013
3 Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis Allergy, April 19, 2013
4 Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies European Journal of Cancer, April 19, 2013 Review Article
5 Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status Journal of Clinical Oncology, April 25, 2013
6 Prognostic and predictive value of estrogen receptor 1 (ESR1) expression in completely resected non-small cell lung cancer (NSCLC) International Journal of Cancer, April 22, 2013
7 Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Annals of Oncology, May 6, 2013
8 Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: Potential value in the clinic Lung Cancer, May 14, 2013
9 Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients data The Lancet Oncology, May 15, 2013 Review Article
10 Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children Cochrane Reviews, May 3, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor